Press Releases for GERN

Press Releases
Corning Incorporated and Geron Corporation Showcase New Synthetic Surface Matrices to Enhance Stem Cell Growth
SmallCapSentinel.com: Bone Marrow Stem Cell Company Profile Released
StockPreacher.com Issues Trading Outlook for Advanced Cell Technology Inc.
Geron Corporation Reports 2009 Second Quarter Financial Results and Events
Geron Announces Conference Call to Discuss Financial Results for the 2009 Second Quarter
BenchmarkJournal.Com Free Analyst Review for QLGC, NEXM, GERN, ENDP, LOGI and ALXN
InvestorSoup.Com Issues Investment Report for Geron Corp.
Geron Scientists and Collaborators Publish Data Showing Functional Dendritic Cells Can Be Derived from Human Embryonic Stem Cells Using Scalable Production Methods
GE Healthcare and Geron Announce Exclusive Global Agreement to Commercialize Stem Cell Drug Discovery Technologies
Geron to Present at the 8th Annual Needham Life Sciences Conference
Geron Corporation Reports 2009 First Quarter Financial Results and Events
Geron Announces Conference Call to Discuss Financial Results for the 2009 First Quarter
Geron Appoints Stephen Kelsey as Executive Vice President and Chief Medical Officer for Oncology, and Hassan Movahhed as Vice President of Clinical Operations for Oncology
Geron Presentations on Imetelstat (GRN163L) at the AACR 2009 Annual Meeting
Geron Corporation Appoints Karin Eastham to Its Board of Directors
Geron Corporation Reports Fourth Quarter and Annual 2008 Financial Results and Highlights
Geron Corporation Announces Pricing of Common Stock Offering
Geron Appoints Audit Committee Members
Geron to Present at BIO CEO & Investor Conference
Geron Announces John Walker Resigns as Director
Geron Receives FDA Clearance to Begin World’s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug Trial in Patients with Multiple Myeloma
Geron Announces Initiation of Phase I Clinical Trial of Vaccine Candidate Targeting Telomerase by Merck & Co., Inc.
Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal
Rescinding the Ban on Embryonic Stem Cell Research: Experts Speak Out on What's Next for This Area of Biotechnology
Geron Corporation to Present at Lazard Capital Markets Healthcare Conference
Geron to Present at Rodman & Renshaw Annual Global Investment Conference
Geron Scientists and Collaborators Demonstrate TAT2 - A Small Molecule Telomerase Activator - Enhances Antiviral Function of Immune Cells From HIV+ Donors
Geron Corporation Reports 2008 Third Quarter Financial Results and Events
Start Licensing, Inc. Sues RNL Bio Ltd. for Patent Infringement
Geron Corporation to Present at 7th Annual Bio Investor Forum
Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-Like Cells Derived From Human Embryonic Stem Cells in Diabetes
Geron Initiates Clinical Trial of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
Geron's GRN163L Sensitizes Resistant Breast Cancer Cells to Trastuzumab in Preclinical Study
Stem Cell Trendsetters in Neurology and Psychiatry Analyzed by NeuroInsights
Geron Supports Governor's Veto of SB1565
Geron Corporation to Present at UBS Global Life Sciences Conference
Geron Announces Issuance of U.S. Patent for Cardiomyocytes From Human Embryonic Stem Cells
Geron Corporation to Present at Thomas Weisel Partners Healthcare Conference
Geron and Exeter Life Sciences Merge Start Licensing and ViaGen to Form Combined Licensing and Operating Company for Animal Cloning Technologies
Geron Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
Geron Corporation Reports 2008 Second Quarter Financial Results and Events
Start Licensing, Inc. Reaffirms Control of Key Cloning Patents
Geron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System
Wall Street Media Presents Exclusive Videos from the Needham Biotech Conference
Geron Corporation to Present at Needham & Company Biotechnology and Medical Technology Conference
Geron Presentations at the ASCO 2008 Annual Meeting
Start Licensing Grants BioArts International Sole License with Exclusive Rights to Clone Dogs and Cats - Jun 3 2008 3:18AM
Start Licensing Grants BioArts International Sole License with Exclusive Rights to Clone Dogs and Cats - May 27 2008 12:59AM
Stock Market Watch for Thursday, May 15, 2008: PUBM Attains True Milestone! - May 27 2008 1:23AM
FDA Places Geron's GRNOPC1 IND on Clinical Hold - May 27 2008 12:53AM
FDA Places Geron's GRNOPC1 IND on Clinical Hold - Jun 3 2008 3:16AM
Geron Corporation to Present at Bank of America Health Care Conference - Jun 3 2008 3:15AM
University of Edinburgh Human Embryonic Stem Cell Program Awarded UK Grant Funding - Jun 3 2008 3:13AM
Geron Reports 2008 First Quarter Financial Results
Geron Announces Conference Call to Discuss Financial Results for the 2008 First Quarter
Geron Presentations at the AACR 2008 Annual Meeting
Geron Receives Milestone Payment From Exeter Life Sciences